Rapid Micro Biosystems Inc (RPID)
0.8214
+0.02
(+2.67%)
USD |
NASDAQ |
May 13, 16:00
0.8399
+0.02
(+2.26%)
Pre-Market: 20:00
Rapid Micro Biosystems Revenue (Quarterly): 5.611M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.611M |
| December 31, 2023 | 6.337M |
| September 30, 2023 | 6.145M |
| June 30, 2023 | 5.002M |
| March 31, 2023 | 5.035M |
| December 31, 2022 | 4.374M |
| September 30, 2022 | 4.739M |
| June 30, 2022 | 3.86M |
| March 31, 2022 | 4.16M |
| Date | Value |
|---|---|
| December 31, 2021 | 5.208M |
| September 30, 2021 | 6.899M |
| June 30, 2021 | 6.13M |
| March 31, 2021 | 4.995M |
| December 31, 2020 | 5.238M |
| September 30, 2020 | 5.247M |
| June 30, 2020 | 2.593M |
| March 31, 2020 | 2.999M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.593M
Minimum
Jun 2020
6.899M
Maximum
Sep 2021
4.975M
Average
5.035M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| Ainos Inc | 0.0199M |
| OpGen Inc | 0.699M |
| Zomedica Corp | 6.262M |
| LENSAR Inc | 12.10M |
| Eargo Inc (DELISTED) | 8.27M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.32M |
| Total Expenses (Quarterly) | 19.88M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | -44.33M |
| Gross Profit Margin (Quarterly) | -27.14% |
| Profit Margin (Quarterly) | -237.4% |
| Earnings Yield | -147.3% |
| Normalized Earnings Yield | -147.32 |